| Ident. | Authors (with country if any) | Title |
|---|
| 000030 (2020) |
Yeyan He [République populaire de Chine] ; Chanying Zheng [République populaire de Chine] | [Replication and transmission mechanisms of highly pathogenic human coronaviruses]. |
| 000048 (2020) |
M. Liu [République populaire de Chine] ; R E Feng [République populaire de Chine] ; Q. Li [République populaire de Chine] ; H K Zhang [République populaire de Chine] ; Y G Wang [République populaire de Chine] | [Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV coronavirus]. |
| 000196 (2020) |
Ning Wang [États-Unis] ; Jian Shang [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Lanying Du [États-Unis] | Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses |
| 000426 (2020) |
James Lyons-Weiler | Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity |
| 000429 (2020) |
Jia Liu [République populaire de Chine] ; Xin Zheng [République populaire de Chine] ; Qiaoxia Tong [République populaire de Chine] ; Wei Li [République populaire de Chine] ; Baoju Wang [République populaire de Chine] ; Kathrin Sutter [Allemagne] ; Mirko Trilling [Allemagne] ; Mengji Lu [Allemagne] ; Ulf Dittmer [Allemagne] ; Dongliang Yang [République populaire de Chine] | Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. |
| 000610 (2020) |
Jasper Fuk-Woo Chan [République populaire de Chine] ; Kin-Hang Kok [République populaire de Chine] ; Zheng Zhu [République populaire de Chine] ; Hin Chu [République populaire de Chine] ; Kelvin Kai-Wang To [République populaire de Chine] ; Shuofeng Yuan [République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine] | Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan |
| 000A01 (2020) |
Yair Cárdenas-Conejo [Mexique] ; Andr Meda Li An-Rico [Mexique] ; Daniel Alejandro García-Rodríguez [Mexique] ; Sara Centeno-Leija [Mexique] ; Hugo Serrano-Posada [Mexique] | An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human-pathogenic coronavirus (SARS-CoV-2). |
| 000A18 (2020) |
Sin-Yee Fung [Hong Kong] ; Kit-San Yuen [Hong Kong] ; Zi-Wei Ye [Hong Kong] ; Chi-Ping Chan [Hong Kong] ; Dong-Yan Jin [Hong Kong] | A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses |
| 000B03 (2019) |
Jean K. Millet ; Tiffany Tang [États-Unis] ; Lakshmi Nathan [États-Unis] ; Javier A. Jaimes [États-Unis] ; Hung-Lun Hsu ; Susan Daniel [États-Unis] ; Gary R. Whittaker [États-Unis] | Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting. |
| 000C09 (2018) |
Stacy R. Webb [États-Unis] ; Stacy E. Smith [États-Unis] ; Michael G. Fried [États-Unis] ; Rebecca Ellis Dutch [États-Unis] | Transmembrane Domains of Highly Pathogenic Viral Fusion Proteins Exhibit Trimeric Association In Vitro. |
| 000C55 (2018) |
Jie Cui ; Fang Li [États-Unis] ; Zheng-Li Shi | Origin and evolution of pathogenic coronaviruses |
| 000D63 (2017) |
Sumei Li [République populaire de Chine] ; Xiuhua Jia [République populaire de Chine] ; Xintian Shen [République populaire de Chine] ; Zhuwen Wei [République populaire de Chine] ; Zhiyan Jiang [République populaire de Chine] ; Yixian Liao [République populaire de Chine] ; Yiming Guo [République populaire de Chine] ; Xiaojun Zheng [République populaire de Chine] ; Guohua Zhong [République populaire de Chine] ; Gaopeng Song [République populaire de Chine] | Structure-activity relationships of 3-O-β-chacotriosyl oleanic acid derivatives as entry inhibitors for highly pathogenic H5N1 influenza virus. |
| 000D90 (2017) |
Rudragouda Channappanavar ; Stanley Perlman | Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology |
| 000E07 (2017) |
Franziska Schandock ; Camilla Frich Riber ; Annika Röcker ; Janis A. Müller ; Mirja Harms ; Paulina Gajda ; Kaja Zuwala ; Anna H. F. Andersen ; Kaja Borup L Vschall ; Martin Tolstrup ; Florian Kreppel ; Jan Münch ; Alexander N. Zelikin | Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses |
| 000E36 (2017) |
Mohammad K. Parvez [Arabie saoudite] ; Shama Parveen | Evolution and Emergence of Pathogenic Viruses: Past, Present, and Future. |
| 000E69 (2017) |
Robert Jordan ; Alison Hogg ; Travis Warren ; Emmie De Wit ; Timothy Sheahan ; Michael Lo ; Veronica Soloveva ; Jessica Weidner ; Laura Gomba ; Friederike Feldmann ; Jacqueline Cronin ; Amy Sims ; Adam Cockrell ; Joy Feng ; Iva Trantcheva ; Darius Babusis ; Danielle Porter-Poulin ; Roy Bannister ; Richard Mackman ; Dustin Siegel ; Adrian Ray ; Mark Denison [États-Unis] ; Christina Spiropoulou ; Stuart Nichol ; Tomas Cihlar ; Ralph Baric ; Heinrich Feldmann ; Sina Bavari | Broad-spectrum Investigational Agent GS-5734 for the Treatment of Ebola, MERS Coronavirus and Other Pathogenic Viral Infections with High Outbreak Potential |
| 001032 (2016) |
David J. Weber [États-Unis] ; William A. Rutala [États-Unis] ; William A. Fischer [États-Unis] ; Hajime Kanamori [États-Unis] ; Emily E. Sickbert-Bennett [États-Unis] | Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9) |
| 001200 (2015) |
Aleksandra A. Zasada | [Selection of disposable personal protective equipment for work with samples containing highly pathogenic microorganisms]. |
| 001216 (2015) |
Renxi Wang [République populaire de Chine] ; He Xiao [République populaire de Chine] ; Renfeng Guo [États-Unis, Allemagne] ; Yan Li [République populaire de Chine] ; Beifen Shen [République populaire de Chine] | The role of C5a in acute lung injury induced by highly pathogenic viral infections |
| 001603 (2014) |
Vineet D. Menachery [États-Unis] ; Amie J. Eisfeld [États-Unis] ; Alexandra Sch Fer [États-Unis] ; Laurence Josset [États-Unis] ; Amy C. Sims [États-Unis] ; Sean Proll [États-Unis] ; Shufang Fan [États-Unis] ; Chengjun Li [États-Unis] ; Gabriele Neumann [États-Unis] ; Susan C. Tilton [États-Unis] ; Jean Chang [États-Unis] ; Lisa E. Gralinski [États-Unis] ; Casey Long [États-Unis] ; Richard Green [États-Unis] ; Christopher M. Williams [États-Unis] ; Jeffrey Weiss [États-Unis] ; Melissa M. Matzke [États-Unis] ; Bobbie-Jo Webb-Robertson [États-Unis] ; Athena A. Schepmoes [États-Unis] ; Anil K. Shukla [États-Unis] ; Thomas O. Metz [États-Unis] ; Richard D. Smith [États-Unis] ; Katrina M. Waters [États-Unis] ; Michael G. Katze ; Yoshihiro Kawaoka [États-Unis] ; Ralph S. Baric [États-Unis] | Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses. |
| 001856 (2013) |
Luca Zinzula ; Enzo Tramontano | Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: Hide, mask, hit |
